ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1573

Salivary Dysbiosis Correlates with Clinical Status of Anti-Ro Positive Mothers of Children with Neonatal Lupus

Robert M. Clancy1, Carl Langefeld2, Hannah C. Ainsworth3, Martin Blaser4, Peter M. Izmirly5, Corey Lacher1, Miranda C Marion6, Mala Masson1, Gregg Silverman7 and Jill P. Buyon1, 1NYU School of Medicine, New York, NY, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Director of the NYU Human Microbiome Program, NYU School of Medicine, New York, NY, 5Rheumatology, NYU School of Medicine, New York, NY, 6Biostatistical Sciences and Center for Public Health Genomics, Wake Forest School of Medicine, Winston-Salem, NC, 7Dept of Medicine, NYU School of Medicine, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoantibodies, Biomarkers, classification criteria and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Neonatal lupus is linked to the presence of circulating anti-Ro antibodies in the mother. These antibodies are present in asymptomatic individuals, who in a subset years later progress to develop overt autoimmune disease. This study was initiated to investigate whether an environmental trigger such as oral colonization by autoreactivity-inducing commensals may contribute to pathgenesis. This goal was approached by leveraging agnostic profiling of the salivary microbiome to identify pathobionts associated with disease outcome in high titer anti-Ro positive women of children with neonatal lupus.

Methods: The study included 24 anti-Ro+ women from the Research Registry for Neonatal Lupus (RRNL) with nine being asymptomatic or having insufficient criteria for Sjögren’s Syndrome (SS) and/or ACR/SLICC SLE (incomplete diagnoses) and 9 SS, 2 SLE, and 4 SS/SLE (established diagnoses) . The rheumatologic diagnoses of the RRNL women were independently determined by two rheumatologists via questionnaire, telephone interview, and/or in-person history/physical exam, and review of medical records. An additional 7 healthy women served as controls. After extraction of host and non-host genomic DNA from saliva (without use of artificial saliva or stimulants), the microbiome was assessed by 16S rRNA gene library analysis using standard protocols (mean of 20k reads per sample). Operational taxonomic units (OTUs) were identified by closed-reference OTU-picking using Green Genes as reference. Shannon’s index, a mathematical measure of species diversity (H’) and relative abundance, was tested for differences using the Kruskal-Wallis tests.

Results: H’ was different for virtually all taxa. At the phylum level, H’ was significantly lower in RRNL vs controls (1.33 vs 1.53 respectively, p=0.018). Significance was retained down to the family level (2.46 vs 2.82 respectively, p=0.007). Contrasting RRNL with controls identified six phyla and 19 families having significant differences in relative abundance (p<0.05). For example, at the family level, Porphyromonadaceae, Fusobacteriaceae, Pasteurellaceae, and Flavobacteriaceae were less abundant in RRNL compared to controls (p=0.003, p=0.004, p=0.030, p=0.038, respectively). In contrast, Peptostreptococcaceae, Weeksellaceae, Coriobacteriaceae and Prevotellaceae were significantly more abundant (p=0.001, p=0.003, p=0.0081, p=0.0421, respectively) in the RRNL. Using a model with comparisons to healthy controls and with RRNL divided into the two subgroups (i.e., incomplete and complete, as described in the methods), the three-group test retained this pattern of significance and differential relative abundance down to the family phylogenetic level, except for Flavobacteriaceae which still showed a similar trend (p=0.08).

Conclusion: These data support a decrease in the diversity of the oral microbiota in anti-Ro positive women, especially in those with established autoimmune diseases such as SS. Our evidence of concurrent increases in relative abundance of organisms, such as inflammatory-provoking Prevotellaceae, may provide insight into disease evolution in a predisposed host.


Disclosure: R. M. Clancy, None; C. Langefeld, None; H. C. Ainsworth, None; M. Blaser, None; P. M. Izmirly, None; C. Lacher, None; M. C. Marion, None; M. Masson, None; G. Silverman, None; J. P. Buyon, Exagen, 2.

To cite this abstract in AMA style:

Clancy RM, Langefeld C, Ainsworth HC, Blaser M, Izmirly PM, Lacher C, Marion MC, Masson M, Silverman G, Buyon JP. Salivary Dysbiosis Correlates with Clinical Status of Anti-Ro Positive Mothers of Children with Neonatal Lupus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/salivary-dysbiosis-correlates-with-clinical-status-of-anti-ro-positive-mothers-of-children-with-neonatal-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/salivary-dysbiosis-correlates-with-clinical-status-of-anti-ro-positive-mothers-of-children-with-neonatal-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology